34 results
8-K
EX-99.1
INVA
Innoviva Inc
29 Feb 24
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
4:15pm
outstanding debt of nearly $100 million. We believe our diversified growth strategy, a strong leadership team, and our focus on cost discipline position us
8-K
EX-99.1
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
of Stephen Basso as its Chief Financial Officer, effective August 21, 2023.
“We are excited to welcome Stephen to our executive leadership team … services industry and financial leadership in the pharmaceutical industry. Prior to joining Innoviva, Mr. Basso served as Chief Financial Officer and Chief
8-K
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
in the financial services industry and financial leadership in the pharmaceutical industry. Prior to joining Innoviva, Mr. Basso served as Chief … Financial Officer and Chief Operating Officer at Cybrexa Therapeutics. Before Cybrexa, Mr. Basso held a variety of finance leadership positions
DEFA14A
96jnn 89wh9
28 Apr 23
Additional proxy soliciting materials
8:38pm
8-K
EX-99.1
ukyci dcd89gbb
28 Apr 23
Innoviva Announces Retirement of Board Chairman
8:30pm
SC TO-T
EX-99
ykz471isrbr
25 Jul 22
Third party tender offer statement
8:34am
SC TO-T
EX-99
ih4q8m2 pi
7 Jun 22
Third party tender offer statement
9:04am
SC TO-C
EX-99.1
edaslg33
23 May 22
Information about tender offer
8:54pm
8-K
EX-99
akyr 7xgvvks
9 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
ivd2exf fo
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am